<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02588794</url>
  </required_header>
  <id_info>
    <org_study_id>316/15 S</org_study_id>
    <nct_id>NCT02588794</nct_id>
  </id_info>
  <brief_title>Cytokine Adsorption in Sepsis and Acute Kidney Injury</brief_title>
  <acronym>CASAKI</acronym>
  <official_title>Cytokine Adsorption in Sepsis and Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to reduce the incidence of RIFLE stadium L and E after acute kidney
      injury in patients with severe sepsis/septic shock
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient with proved severe sepsis/septic shock, treated in accordance to actual sepsis
      guidelines, who develope akute kidney injury (RIFLE I) or kidney failure (RIFLE F), were
      randomized in two groups.

      One group is treated with CVVHD/ local citrat anticoagulation (standart clinical practice).

      The other group ist treated with an additional cytokine adsorber ( 300ml CytoSorb device,
      3804606CE01)

      CytoSorb therapy is performed for 24h, then the adsorber is changed into a new device.

      Cytosorb therapy is stopped, when Interleukin 6 leves drop below 1000 pg/ml in patient serum.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RIFLE stadium L or E after acute kidney injury related to sepsis</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of renal replacement therapy</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cumulative dose of vasopressor support</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Renal Insufficiency or Renal Failure &amp;or End-stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standart CVVHD plus CytoSorb 300 ml device (3804606CE01)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standart CVVHD</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CytoSorb 300 ml device (3804606CE01)</intervention_name>
    <description>additional cytokine adsorber</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe sepsis or septic shock according to ESICM guidelines not older than 24 h

        Exclusion Criteria:

          -  preexisting renal disease KDIGO stadium 4 and 5
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kochs Eberhard, Chairman</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthsiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ralph Bogdanski, MD</last_name>
    <phone>+498941405472</phone>
    <email>ralph.bogdanski@tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara Kapfer, MD</last_name>
    <phone>+498941405473</phone>
    <email>b.kapfer@tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Anästhesiologie</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Bogdanski, MD</last_name>
      <phone>+498941405472</phone>
      <email>ralph.bogdanski@tum.de</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Kapfer, MD</last_name>
      <phone>+498941405473</phone>
      <email>b.kapfer@tum.de</email>
    </contact_backup>
    <investigator>
      <last_name>Markus Heim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Günther Edenharter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>October 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <last_update_submitted>October 27, 2015</last_update_submitted>
  <last_update_submitted_qc>October 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technische Universität München</investigator_affiliation>
    <investigator_full_name>Guenther_Edenharter</investigator_full_name>
    <investigator_title>Dr.med.</investigator_title>
  </responsible_party>
  <keyword>sepsis, acute kidney injury , CytoSorb</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

